Ligand Pharmaceuticals Incorporated (LGND) vs Scholar Rock Holding Corporation (SRRK)

Ligand Pharmaceuticals Incorporated and Scholar Rock Holding Corporation are both Biotechnology companies. Ligand Pharmaceuticals Incorporated and Scholar Rock Holding Corporation are of similar size ($6.1B and $6.0B). Scholar Rock Holding Corporation has negative trailing earnings, so its P/E is not meaningful; Ligand Pharmaceuticals Incorporated trades at 30.1×. Scholar Rock Holding Corporation grew revenue faster over the last twelve months: 213.7% against 54.9%. Ligand Pharmaceuticals Incorporated has the higher net margin (67.9% vs 0.00%) and the higher return on invested capital (8.19% vs 0.00%). Across the 17 metrics below, Ligand Pharmaceuticals Incorporated leads on 15 and Scholar Rock Holding Corporation on 2.